NeuroQuant is the first FDA-cleared clinical solution software for brain MRI quantification. NeuroQuant provides fast, accurate, and proven automated brain image analysis via volumetric MRI processing. Easy to integrate into your existing PACS systems, NeuroQuant is designed to replace time-consuming manual processes to accelerate the analysis of brain structures. Cortechs.ai has developed a dynamic brain atlas using thousands of healthy MRI scans, which NeuroQuant uses to compare and report neurological abnormalities in patients that are matched based on age, sex, and intracranial volume. NeuroQuant is used to aid in the accurate diagnosis, tracking, and effective treatment of neurodegenerative, neurodevelopmental & traumatic conditions including MS, Alzheimer’s disease and other dementia, epilepsy, and concussion.
NeuroQuant MS, the automated lesion quantification module of NeuroQuant, combines T2 FLAIR and 3D T1 MRI analysis to provide valuable quantitative data on brain structures and lesions. NeuroQuant MS provides FLAIR lesion and subcortical brain structure quantification, as well as lesion and lesion change visualization reports to aid in the clinical treatment, planning, and disease progression monitoring of patients with white matter diseases, such as Multiple Sclerosis and other neurodegenerative diseases.